A Phase III Study to Evaluate Long-Acting Antiretroviral Therapy in Non-adherent HIV Infected Individuals
||Male and Female Patients
|U.S. Govt. ID:
||Anyelina Cantos: 212-305-7897 / firstname.lastname@example.org
We are doing a research study to find out if Long-Acting Injectable anti-HIV medications will be more successful than standard pills for people who have a hard time taking their HIV pills. If you are over the age of 18 years old, have been prescribed HIV medications but have had difficulty getting undetectable viral load (when the levels of virus in the bloodstream are so low that they can't be measured), you may be eligible. You may receive up to $1100 for the first 5 months of participation. Contact us to find out more about this study.
Michael Yin, MD
|Are you 18 years of age or older?
|Are you HIV+ (HIV positive)?